Literature DB >> 16555834

Computationally guided organometallic chemistry: preparation of the heptacyclic pyrazine core of ritterazine N.

Douglass F Taber1, Karen V Taluskie.   

Abstract

Diels-Alder cycloaddition of 10 followed by Wittig homologation and intramolecular diene cyclozirconation of the resulting triene under equilibrating conditions led to the tricyclic 6-6-5 ketone 5 with high diastereocontrol. The derived alpha-azido ketone 16 cyclized efficiently to the heptacyclic pyrazine core of ritterazine N.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16555834      PMCID: PMC3248823          DOI: 10.1021/jo052656m

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  7 in total

1.  Stereoselective synthesis of structurally simplified cephalostatin analogues by multiple Heck reactions and their biological evaluation.

Authors:  Lutz F Tietze; Wolf-Rüdiger Krahnert
Journal:  Chemistry       Date:  2002-05-03       Impact factor: 5.236

2.  Isolation of 13 New Ritterazines from the Tunicate Ritterella tokioka and Chemical Transformation of Ritterazine B(1).

Authors:  Seketsu Fukuzawa; Shigeki Matsunaga; Nobuhiro Fusetani
Journal:  J Org Chem       Date:  1997-06-27       Impact factor: 4.354

3.  Cephalostatin 1 inactivates Bcl-2 by hyperphosphorylation independent of M-phase arrest and DNA damage.

Authors:  Irina M Müller; Verena M Dirsch; Anita Rudy; Nancy López-Antón; George R Pettit; Angelika M Vollmar
Journal:  Mol Pharmacol       Date:  2005-02-09       Impact factor: 4.436

4.  An efficient synthesis of the C-23 deoxy, 17 alpha-hydroxy South 1 hemisphere and its cephalostatin 1 analog.

Authors:  Wei Li; Philip L Fuchs
Journal:  Org Lett       Date:  2003-08-07       Impact factor: 6.005

5.  Cephalostatin 1 selectively triggers the release of Smac/DIABLO and subsequent apoptosis that is characterized by an increased density of the mitochondrial matrix.

Authors:  Verena M Dirsch; Irina M Müller; Sören T Eichhorst; George R Pettit; Yoshiaki Kamano; Masuo Inoue; Jun-Ping Xu; Yoshitatsu Ichihara; Gerhard Wanner; Angelika M Vollmar
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

6.  Ritterazine B, a new cytotoxic natural compound, induces apoptosis in cancer cells.

Authors:  Takefumi Komiya; Nobuhiro Fusetani; Shigeki Matsunaga; Akihito Kubo; Frederic J Kaye; Michael J Kelley; Kenji Tamura; Makoto Yoshida; Masahiro Fukuoka; Kazuhiko Nakagawa
Journal:  Cancer Chemother Pharmacol       Date:  2003-01-14       Impact factor: 3.333

7.  Antineoplastic agents. 398. Isolation and structure elucidation of cephalostatins 18 and 19.

Authors:  G R Pettit; R Tan; J Xu; Y Ichihara; M D Williams; M R Boyd
Journal:  J Nat Prod       Date:  1998-07       Impact factor: 4.050

  7 in total
  5 in total

1.  Preparation of the 5/5-spiroketal of the ritterazines.

Authors:  Douglass F Taber; Jean-Michel Joerger
Journal:  J Org Chem       Date:  2007-03-31       Impact factor: 4.354

Review 2.  Chemistry of trisdecacyclic pyrazine antineoplastics: the cephalostatins and ritterazines.

Authors:  Seongmin Lee; Thomas G LaCour; Philip L Fuchs
Journal:  Chem Rev       Date:  2009-06       Impact factor: 60.622

3.  Importance of a 4-Alkyl Substituent for Activity in the Englerin Series.

Authors:  Daniel C Elliott; John A Beutler; Kathlyn A Parker
Journal:  ACS Med Chem Lett       Date:  2017-06-06       Impact factor: 4.345

4.  Construction of the tricyclic A-B-C core of the Veratrum alkaloids.

Authors:  Douglass F Taber; James F Berry
Journal:  J Org Chem       Date:  2013-08-06       Impact factor: 4.354

5.  Synthesis of C14,15-dihydro-C22,25-epi north unit of cephalostatin 1 via "red-ox" modifications of hecogenin acetate.

Authors:  Seongmin Lee; Daniel Jamieson; Philip L Fuchs
Journal:  Org Lett       Date:  2009-01-01       Impact factor: 6.005

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.